Skip to main content
Clinical Trials/NCT05317884
NCT05317884
Completed
Not Applicable

Evaluation of Email-based Reminders in Promoting Adherence to the Recommended Pediatric Preventative-visit Schedule Among Rural Patients

Geisinger Clinic1 site in 1 country1,186 target enrollmentMay 16, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Immunization Programs
Sponsor
Geisinger Clinic
Enrollment
1186
Locations
1
Primary Endpoint
WCC visit scheduled
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to assess, prospectively, the effect of email reminders for well-child check (WCC) visits on adherence to these visits among those who have not yet scheduled the visit. The investigators hypothesize that sending reminders will increase scheduling WCC visits, attending WCC visits, and being up to date for the child's required immunizations beyond what occurs in the absence of these reminders.

Detailed Description

Regular attendance at recommended WCC visits is associated with having up-to-date immunizations. Standard care involves scheduling a follow-up WCC visit at the end of the current visit. However, if the child's parents do not choose to schedule a follow-up visit at that time or miss a WCC visit, they may not be offered another easy opportunity to schedule one. That is, they would have to remember to schedule a visit and contact the clinic proactively. In this study, 30 days before a child is due for their WCC visit, parents who have not yet scheduled a WCC visit for up to 30 days (for 5-month-olds) or 60 days (for all other ages) after their child is due for a visit will be randomly assigned to two groups with a random number generator. One group will receive an email reminder, while the other group will not receive any reminder. The randomization of participants to different conditions will be in place until 800 participants have been identified and randomly assigned to one of the arms (estimated sample to detect at least a 10% absolute difference) or 180 days, whichever comes first. To account for delays in updating clinical databases, the final outcome data will be checked 90 days after the last eligible visit (for a maximum study period of 270 days).

Registry
clinicaltrials.gov
Start Date
May 16, 2022
End Date
September 13, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Amir Goren

Program Director, Behavioral Insights Team

Geisinger Clinic

Eligibility Criteria

Inclusion Criteria

  • Parents (or contact on record) of children aged 5, 8, 11, 14, or 17 months
  • No WCC visits scheduled 30 days after the child's monthly birthday (for 5 month-olds) or 60 days (for all other ages) ahead of their due date for a WCC (i.e., month 6, 9, 12, 15, or 18)
  • Has an email address on record
  • Child is currently seen in Pediatric clinics under the Geisinger umbrella (has at least one prior visit)

Exclusion Criteria

  • Did not opt out of emails

Outcomes

Primary Outcomes

WCC visit scheduled

Time Frame: 30-60 days from the email send date

Binary variable of scheduling a WCC visit as established by visit type, visit reasons, and billing codes (if available)

Secondary Outcomes

  • WCC visit made(30-60 days from the email send date)
  • Immunization status(60 days from the email send date)

Study Sites (1)

Loading locations...

Similar Trials